These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24602937)

  • 1. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.
    Brennan BM; Coyle JR; Marchaim D; Pogue JM; Boehme M; Finks J; Malani AN; VerLee KE; Buckley BO; Mollon N; Sundin DR; Washer LL; Kaye KS
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):342-9. PubMed ID: 24602937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.
    Bhargava A; Hayakawa K; Silverman E; Haider S; Alluri KC; Datla S; Diviti S; Kuchipudi V; Muppavarapu KS; Lephart PR; Marchaim D; Kaye KS
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):398-405. PubMed ID: 24602945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region.
    Pfeiffer CD; Cunningham MC; Poissant T; Furuno JP; Townes JM; Leitz A; Thomas A; Buser GL; Arao RF; Beldavs ZG
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):356-61. PubMed ID: 24602939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Distribution of Educational Materials for Carbapenem-Resistant Enterobacteriaceae Among Acute and Long-term Care Facilities.
    Kram JJ; Borlaug G; Safdar N; Sethi A
    WMJ; 2015 Apr; 114(2):48-51. PubMed ID: 26756056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.
    Marchaim D; Chopra T; Perez F; Hayakawa K; Lephart PR; Bheemreddy S; Blunden C; Hujer AM; Rudin S; Shango M; Campbell M; Varkey J; Slim J; Ahmad F; Patel D; Chen TY; Pogue JM; Salimnia H; Dhar S; Bonomo RA; Kaye KS
    Infect Control Hosp Epidemiol; 2011 Sep; 32(9):861-71. PubMed ID: 21828966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.
    Guh AY; Bulens SN; Mu Y; Jacob JT; Reno J; Scott J; Wilson LE; Vaeth E; Lynfield R; Shaw KM; Vagnone PM; Bamberg WM; Janelle SJ; Dumyati G; Concannon C; Beldavs Z; Cunningham M; Cassidy PM; Phipps EC; Kenslow N; Travis T; Lonsway D; Rasheed JK; Limbago BM; Kallen AJ
    JAMA; 2015 Oct; 314(14):1479-87. PubMed ID: 26436831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD; Shorr AF
    J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
    Lee GC; Lawson KA; Burgess DS
    Ann Pharmacother; 2013 Sep; 47(9):1115-21. PubMed ID: 24259725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
    Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A
    PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge.
    Zimmerman FS; Assous MV; Bdolah-Abram T; Lachish T; Yinnon AM; Wiener-Well Y
    Am J Infect Control; 2013 Mar; 41(3):190-4. PubMed ID: 23449280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
    Thiébaut AC; Arlet G; Andremont A; Papy E; Sollet JP; Bernède-Bauduin C; Guillemot D; Schlemmer B;
    J Antimicrob Chemother; 2012 Jun; 67(6):1525-36. PubMed ID: 22441577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vital signs: carbapenem-resistant Enterobacteriaceae.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(9):165-70. PubMed ID: 23466435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.
    Schwaber MJ; Carmeli Y
    Clin Infect Dis; 2014 Mar; 58(5):697-703. PubMed ID: 24304707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
    Viale P; Tumietto F; Giannella M; Bartoletti M; Tedeschi S; Ambretti S; Cristini F; Gibertoni C; Venturi S; Cavalli M; De Palma A; Puggioli MC; Mosci D; Callea E; Masina R; Moro ML; Lewis RE
    Clin Microbiol Infect; 2015 Mar; 21(3):242-7. PubMed ID: 25658534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area.
    Cheng VC; Chan JF; Wong SC; Chen JH; Tai JW; Yan MK; Kwan GS; Tse H; To KK; Ho PL; Yuen KY
    Chin Med J (Engl); 2013 Dec; 126(23):4504-9. PubMed ID: 24286415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?
    Schechner V; Kotlovsky T; Kazma M; Mishali H; Schwartz D; Navon-Venezia S; Schwaber MJ; Carmeli Y
    Clin Microbiol Infect; 2013 May; 19(5):451-6. PubMed ID: 22563800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
    Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
    J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of carbapenem-resistant enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions.
    Chitnis AS; Caruthers PS; Rao AK; Lamb J; Lurvey R; Beau De Rochars V; Kitchel B; Cancio M; Török TJ; Guh AY; Gould CV; Wise ME
    Infect Control Hosp Epidemiol; 2012 Oct; 33(10):984-92. PubMed ID: 22961017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.
    Hyle EP; Ferraro MJ; Silver M; Lee H; Hooper DC
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1242-9. PubMed ID: 21029005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.